Top Midday Gainers

Omeros (OMER) said Wednesday the US Food and Drug Administration has approved Yartemlea to treat hem
PREMIUM
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
Upgrade
Already have a subscription? Sign in
Google